ÂÜÀòÂÒÂ×

Melissa Lee-Sundlov, Ph.D. has a diverse work experience in research and scientific roles. Their most recent position is as a Senior Manager of Clinical Science and Translational Research at Vor Biopharma, starting in January 2022. Prior to this, they worked at Versiti Inc. as a Research Scientist from an unknown start date until January 2022. In this role, they were involved in various research projects in the fields of hematology and immunology, collaborating with internal and external partners and contributing to successful publications. Melissa also served as an external consultant to Pfizer, providing expertise on exploratory endpoints for a Phase 3 clinical trial.

Before their time at Versiti Inc., Melissa worked as a Research Fellow at Brigham and Women's Hospital and Harvard Medical School from March 2015 to December 2016. Their research focused on understanding the role of glycan-mediated platelet clearance in regulating hematopoietic stem cells in the bone marrow. Melissa made significant contributions in identifying a novel growth factor and its binding partner, which influenced the hematopoietic stem cell niche.

Prior to that, Melissa held the position of a Postdoctoral Research Affiliate at Roswell Park Cancer Institute from October 2011 to February 2015. Their research at Roswell Park focused on the role of platelets in modifying glycans on blood cells and investigating the enzymatic capability of glycosyltransferase enzymes in circulation. Melissa also participated in the Mentorship in Undergraduate Science Education (MUSE) Program, collaborating with faculty from Canisius College and designing lectures for undergraduate students.

Melissa's work experience began at The State University of New York, where they served as a Research Assistant from May 2008 to August 2011. Their research involved the development of small-molecule ligands that targeted myotonic dystrophy RNAs for potential therapeutic applications. Melissa worked on optimizing ligand binding and cellular delivery in the nuclear cell compartment where the diseased RNAs are located.

Furthermore, Melissa has teaching experience as a Teaching Assistant at the University at Buffalo from August 2006 to May 2008. Melissa taught recitation and laboratory sessions for college-level General Chemistry, focusing on conceptual understanding rather than rote memorization.

Overall, Melissa Lee-Sundlov, Ph.D. has a strong background in research, scientific collaboration, and teaching, with a focus on hematology, immunology, and molecular biology.

Melissa Lee-Sundlov, Ph.D., completed their education at the University at Buffalo. From 2006 to 2011, they pursued their doctoral degree in Chemistry with a specialization in Chemical Biology. Prior to that, from 2003 to 2006, they obtained their Bachelor of Science degree in Chemistry, focusing on Medicinal Chemistry, from the same university. Additionally, there is mention of their experience at the Roswell Park Cancer Institute, but no specific degree or field of study is provided, so it is unclear if they obtained any formal education from this institute.